These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10193311)

  • 1. Hepatitis B virus (HBV)-transgenic mice as an investigative tool to study immunopathology during HBV infection.
    Akbar SK; Onji M
    Int J Exp Pathol; 1998 Oct; 79(5):279-91. PubMed ID: 10193311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of antibody to hepatitis B surface antigen (anti-HBs) by murine hepatitis B virus carriers: neonatal tolerance versus antigen presentation by dendritic cells.
    Kurose K; Akbar SM; Yamamoto K; Onji M
    Immunology; 1997 Dec; 92(4):494-500. PubMed ID: 9497491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.
    Martinet J; Leroy V; Dufeu-Duchesne T; Larrat S; Richard MJ; Zoulim F; Plumas J; Aspord C
    Hepatology; 2012 Nov; 56(5):1706-18. PubMed ID: 22707082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells and chronic hepatitis virus carriers.
    Akbar SM; Horiike N; Onji M; Hino O
    Intervirology; 2001; 44(4):199-208. PubMed ID: 11509880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of a hepatitis B virus carrier transgenic mice model].
    Caner M; Arat S; Bircan R
    Mikrobiyol Bul; 2008 Jan; 42(1):71-81. PubMed ID: 18444564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication and gene expression of mutant hepatitis B virus in a transgenic mouse containing the complete viral genome with mutant s gene.
    Ge JH; Zhang LZ; Li JX; Liu H; Liu HM; He J; Yao YC; Yang YJ; Yu HY; Hu YP
    World J Gastroenterol; 2004 Nov; 10(21):3141-5. PubMed ID: 15457560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A transgenic mouse model of the chronic hepatitis B surface antigen carrier state.
    Chisari FV; Pinkert CA; Milich DR; Filippi P; McLachlan A; Palmiter RD; Brinster RL
    Science; 1985 Dec; 230(4730):1157-60. PubMed ID: 3865369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice.
    Yu D; Liu H; Shi S; Dong L; Wang H; Wu N; Gao H; Cheng Z; Zheng Q; Cai J; Zou L; Zou Z
    Immunol Lett; 2015 Dec; 168(2):293-9. PubMed ID: 26475398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of MHC class II antigen on dendritic cells from hepatitis B virus transgenic mice by interferon-gamma: abrogation of immune response defect to a T-cell-dependent antigen.
    Akbar SM; Inaba K; Onji M
    Immunology; 1996 Apr; 87(4):519-27. PubMed ID: 8675204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the hepatitis B virus S‑ecdCD40L vaccine therapy in HBV transgenic mice: A vaccine‑induced activation of antigen presenting dendritic cells.
    Guan H; Lan S; Wu J; Tang B; Xu Y
    Mol Med Rep; 2017 Nov; 16(5):6102-6108. PubMed ID: 28849136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction.
    Suárez-Amarán L; Usai C; Di Scala M; Godoy C; Ni Y; Hommel M; Palomo L; Segura V; Olagüe C; Vales A; Ruiz-Ripa A; Buti M; Salido E; Prieto J; Urban S; Rodríguez-Frias F; Aldabe R; González-Aseguinolaza G
    J Hepatol; 2017 Oct; 67(4):669-679. PubMed ID: 28527664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBV production in transgenic mice.
    Yamamura K; Araki K; Hino O; Tomita N; Miyazaki J; Matsubara K
    Gastroenterol Jpn; 1990 Sep; 25 Suppl 2():49-52. PubMed ID: 2227265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A virus-like particle of the hepatitis B virus preS antigen elicits robust neutralizing antibodies and T cell responses in mice.
    Cai X; Zheng W; Pan S; Zhang S; Xie Y; Guo H; Wang G; Li Z; Luo M
    Antiviral Res; 2018 Jan; 149():48-57. PubMed ID: 29129705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
    Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
    J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent advance in the study of immunopathobiology of hepatitis B virus infection using HBV transgenic mice].
    Kakimi K
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():54-7. PubMed ID: 15453285
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanism and therapeutic potential of DNA-based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice.
    Oka Y; Akbar SM; Horiike N; Joko K; Onji M
    Immunology; 2001 May; 103(1):90-7. PubMed ID: 11380696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable transmission and expression of the hepatitis B virus total genome in hybrid transgenic mice until F10 generation.
    Bagis H; Arat S; Mercan HO; Aktoprakligil D; Caner M; Turanli ET; Baysal K; Turgut G; Sekmen S; Cirakoglu B
    J Exp Zool A Comp Exp Biol; 2006 May; 305(5):420-7. PubMed ID: 16489557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low responsiveness of hepatitis B virus-transgenic mice in antibody response to T-cell-dependent antigen: defect in antigen-presenting activity of dendritic cells.
    Akbar SM; Onji M; Inaba K; Yamamura K; Ohta Y
    Immunology; 1993 Mar; 78(3):468-75. PubMed ID: 8478028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breaking Hepatitis B Virus Tolerance and Inducing Protective Immunity Based on Mimicking T Cell-Independent Antigen.
    Li X; Ni R
    Viral Immunol; 2016 Nov; 29(9):502-509. PubMed ID: 27662269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mouse model with age-dependent immune response and immune-tolerance for HBV infection.
    Yi X; Yuan Y; Li N; Yi L; Wang C; Qi Y; Gong L; Liu G; Kong X
    Vaccine; 2018 Feb; 36(6):794-801. PubMed ID: 29306503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.